EWTX - Company ID 0001710072
The table below shows Edgewise Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $68.68M | $72.32M | $33.21M | $46.00M | $43.40M | $49.92M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.77B |
| $471.52M |
| $509.79M |
| $573.90M |
| $603.25M |
| $443.18M |
| Property, plant & equipment | $6.33M | $6.89M | $7.40M | $8.13M | $8.60M | $8.99M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $1.78B | $479.69M | $518.52M | $583.47M | $613.33M | $454.39M |
| Accounts payable | $9.64M | $4.67M | $7.29M | $6.16M | $8.32M | $8.79M |
| Total current liabilities | $144.11M | $29.04M | $22.54M | $21.65M | $20.90M | $21.11M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $147.35M | $31.61M | $25.32M | $24.82M | $24.26M | $24.67M |
| Retained earnings | $513.44M | -$652.71M | -$595.38M | -$496.15M | -$455.49M | -$419.37M |
| Total equity | $1.63B | $448.08M | $493.20M | $558.65M | $589.07M | $429.72M |